language Türkçe
Article 2022 · 5 citations

In vitro Evaluation of Selective Cytotoxic Activity of <i>Chaerophyllum macropodum</i> Boiss. on Cultured Human SH-SY5Y Neuroblastoma Cells

Celikezen, Fatih Caglar, Turkez, Hasan, Firat, Mehmet, Arslan, Mehmet Enes, Oner, Sena

Abstract

Neuroblastoma is the most common solid tumor in children. New treatment approaches are needed because of the harmful side effects and costs of the methods used in the treatment of neuroblastoma. Medicinal and aromatic plants are important for new treatment approaches due to their minimal side effects and economic advantages. Therefore, the present study was carried out to examine the cytotoxic effect of Chaerophyllum macropodum extract on human neuroblastoma (SH-SY5Y) and fibroblast (HDFa) cell lines. 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase release (LDH) assays were used to determine the cytotoxic effect of C. macropodum. The extracts were analyzed for their phenolic content by HPLC-PDA. Major components were determined as 63.600% o-coumaric acid, 15.606% catechine hydrate, 8.713% rosmarinic acid, 4.376% clorogenic acid, and 3.972% salicylic acid. The obtained results from cytotoxicity testing revealed that C. macropodum exerted a significant cytotoxic effect on human neuroblastoma cells at all tested concentrations (p < 0.05). But it did not lead to any cytotoxic potential on human fibroblasts. As a result, the obtained data clearly revealed C. macropodum exerted a selective cytotoxic action on neuroblastoma cells for the first time.

Keywords
Chaerophyllum macropodum Apiaceae Cytotoxic action Neuroblastoma Anticancer HPLC ANGELICA-KEISKEI ROOTS ANTIMETASTATIC ACTIVITIES CHALCONE CONSTITUENT ANTICANCER ACTIVITY ANTIOXIDANT CANCER APOPTOSIS 4-HYDROXYDERRICIN ANTITUMOR EXTRACTS
WoS Categories
Neurosciences
Sustainable Development Goals
Citation
Journal
NEUROTOXICITY RESEARCH
Year
2022
Volume
40
Issue
5
Pages
1360-1368
ISSN
1029-8428
eISSN
1476-3524
DOI
10.1007/s12640-022-00537-z
WoS UID
WOS:000828989000001
Open via DOI